Fundamentals screen · refreshed after the Nov 10, 2026 close

Largest US companies: Healthcare

US-listed companies ranked by market capitalisation. Market capitalisation is shares outstanding multiplied by the latest close.

CriteriaCommon stockRanked by market cap847 stocks
#CompanyPriceTodayYTDP/EMkt cap
201AUPHAurinia PharmaceuticalsHealthcare$16.30−1.93%+2.2%7.0×$2.18B
202VERAVera TherapeuticsHealthcare$30.03−1.89%−40.7%—$2.17B
203PBHPrestige Consumer HealthcareHealthcare$44.97+2.98%−27.1%13.7×$2.13B
204TRVITrevi TherapeuticsHealthcare$14.91−2.61%+19.1%—$2.13B
205FTREFortrea HoldingsHealthcare$21.39−3.82%+24.0%—$2.06B
206ESTAEstablishment Labs HoldingsHealthcare$67.23−1.88%−7.8%—$2.01B
207HRMYHarmony Biosciences HoldingsHealthcare$33.55−0.68%−10.3%11.0×$1.97B
208ETONEton PharmaceutcialsHealthcare$67.54+4.96%+299.4%39.1×$1.95B
209VCYTVeracyteHealthcare$24.06−7.18%−42.9%15.3×$1.94B
210MAZEMaze TherapeuticsHealthcare$35.45+1.55%−14.4%—$1.94B
211ZBIOZenas BioPharmaHealthcare$28.58+0.04%−21.3%—$1.94B
212BCRXBioCryst PharmaceuticalsHealthcare$7.53−1.31%−3.5%—$1.94B
213XRAYDENTSPLY SIRONAHealthcare$9.70+1.68%−15.1%—$1.93B
214AGLagilon healthHealthcare$113.52−0.44%+559.3%—$1.91B
215AGIOAgios PharmaceuticalsHealthcare$31.76+1.21%+16.7%—$1.90B
216TRLVTrulieve CannabisHealthcare$11.09+0.73%——$1.89B
217KLRAKailera TherapeuticsHealthcare$14.24+3.94%——$1.85B
218COAGHemab Therapeutics HoldingsHealthcare$38.77−9.44%——$1.81B
219LMATLeMaitre VascularHealthcare$79.02−2.64%−2.6%28.5×$1.81B
220INSPInspire Medical SystemsHealthcare$62.31−3.14%−32.4%17.9×$1.80B
221STOKStoke TherapeuticsHealthcare$27.21−1.80%−14.3%—$1.78B
222GENBGenerate BiomedicinesHealthcare$13.78−2.82%——$1.77B
223BRVEBraveheart BioHealthcare$19.62+0.82%——$1.77B
224SRPTSarepta Therapeutics,Healthcare$16.42−4.76%−23.7%119.3×$1.76B
225KMTSKestra Medical TechnologiesHealthcare$29.55−1.89%+11.4%—$1.76B
226BFLYButterfly NetworkHealthcare$6.51−2.40%+71.3%—$1.74B
227NRIXNurix TherapeuticsHealthcare$15.88−1.61%−16.3%5.9×$1.73B
228PSNLPersonalisHealthcare$15.88−0.44%+99.5%—$1.72B
229HCSGHealthcare Services GroupHealthcare$25.30+2.10%+32.3%16.3×$1.71B
230SLSSELLAS Life Sciences GroupHealthcare$8.37−2.45%+122.0%—$1.69B
231NVAXNovavaxHealthcare$10.20−6.34%+51.8%—$1.68B
232SUPNSupernusHealthcare$28.75+4.09%−42.2%—$1.67B
233SNDASonida Senior LivingHealthcare$33.74+1.57%+3.5%—$1.66B
234RAREUltragenyx PharmaceuticalHealthcare$16.14−1.65%−29.8%—$1.65B
235WGSGeneDx HoldingsHealthcare$54.83−16.57%−57.8%—$1.64B
236TDOCTeladoc HealthHealthcare$8.94−0.45%+27.7%—$1.63B
237ENOVEnovisHealthcare$28.22−1.12%+5.9%—$1.63B
238PGENPrecigenHealthcare$4.52−4.44%+8.1%66.4×$1.62B
239ANIPANI PharmaceuticalsHealthcare$71.25+5.10%−9.7%14.9×$1.62B
240QUREuniQureHealthcare$22.71−0.35%−5.1%—$1.59B
241NTLAIntellia TherapeuticsHealthcare$11.17−7.76%+24.2%—$1.57B
242RAPPRapport TherapeuticsHealthcare$25.96−0.42%−14.4%—$1.54B
243CNMDCONMEDHealthcare$51.21−1.41%+26.1%20.8×$1.53B
244EYENational Vision HoldingsHealthcare$19.01+0.21%−26.4%29.9×$1.50B
245DMRADamora TherapeuticsHealthcare$24.15+0.33%——$1.49B
246NUVBNuvation BioHealthcare$4.20−3.45%−53.1%—$1.48B
247USPHUS Physical TherapyHealthcare$99.24−0.60%+27.1%—$1.48B
248PCRXPacira BioSciencesHealthcare$36.49+0.08%+41.0%38.6×$1.46B
249LBRXLB PharmaceuticalsHealthcare$44.94−0.40%+101.9%—$1.45B
250OCULOcular TherapeutixHealthcare$6.61−3.50%−45.6%—$1.45B

Method & sources

Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology

Informational screen, not a recommendation.